ACAD
NASDAQ · Biotechnology
Acadia Pharmaceuticals Inc
$28.75
-0.05 (-0.17%)
Performance
1D
—
1W
—
1M
—
3M
—
6M
+23.82%
1Y
+17.83%
YTD
+9.36%
Open$28.85
Previous Close$28.80
Day High$29.48
Day Low$28.32
52W High$28.35
52W Low$19.69
Volume—
Avg Volume1.38M
Market Cap4.49B
P/E Ratio11.96
EPS$2.19
SectorBiotechnology
Technical Indicators
Full analysis →
SMA 50
$25.91
Above
SMA 200
$23.44
Above
RSI (14)
42.4
Neutral
Trend
Golden Cross
Bullish
Analyst Ratings
Strong Buy
27 analysts
Price Target
-37.7% upside
Current
$28.75
$28.75
Target
$17.90
$17.90
$12.70
$17.90 avg
$23.84
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 1.10B | 962.00M | 1.03B |
| Net Income | 399.59M | 315.94M | 167.73M |
| Profit Margin | 36.5% | 34.7% | 16.3% |
| EBITDA | 108.01M | 90.14M | 233.13M |
| Free Cash Flow | — | — | 189.95M |
| Rev Growth | +13.8% | +13.8% | +10.0% |
| Debt/Equity | — | — | 0.91 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $244.33 | -0.76% | 122.9 | 446.67B |
| AMGN | Amgen Inc | $403.48 | -1.07% | 26.5 | 206.48B |
| GILD | Gilead Sciences Inc | $129.97 | -1.36% | 17.6 | 161.72B |
| VRTX | Vertex Pharmaceuticals Inc | $484.53 | -0.06% | 27.8 | 120.52B |
| REGN | Regeneron Pharmaceuticals | $767.54 | -0.14% | 17.5 | 77.36B |
| ALNY | Alnylam Pharmaceuticals Inc | $217.83 | -4.76% | 47.7 | 27.52B |